Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
104.90
+0.12 (0.11%)
At close: Jul 18, 2025, 4:00 PM
104.96
+0.06 (0.06%)
After-hours: Jul 18, 2025, 5:38 PM EDT
Verona Pharma Revenue
Verona Pharma had revenue of $76.26M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $118.54M. In the year 2024, Verona Pharma had annual revenue of $42.28M.
Revenue (ttm)
$118.54M
Revenue Growth
n/a
P/S Ratio
73.09
Revenue / Employee
$567,153
Employees
209
Market Cap
8.93B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
VRNA News
- 6 days ago - VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire
- 9 days ago - Major deals involving U.S. drugmakers and biotechs over the past decade - Reuters
- 10 days ago - Two big reasons why buying Verona was crucial for Merck - Invezz
- 10 days ago - Merck has struck a roughly $10 billion deal to buy Verona Pharma - WSJ
- 10 days ago - Verona Pharma shares jump with Merck set to acquire company in $10 billion deal - Invezz
- 10 days ago - Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - Market Watch
- 10 days ago - Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck. - Barrons
- 10 days ago - Merck to Buy Verona Pharma in $10 Billion Deal - WSJ